Preprints are likely here to stay. The press, the public, and the research community must adapt to this relatively recent model of scientific publishing if we are to extract its benefits while avoiding its pitfalls.
COVID-19 has killed more than 4 million people around the globe and has sickened many millions more. The neurological toll on those of us continuing to live through the pandemic may stretch years or decades into the uncertain future.
Humanity was hoping to emerge from the COVID-19 pandemic this year. But viruses have plenty of tools at their disposal, and we should plan for a long-term future in which SARS-CoV-2 is a persistent threat.
The resurfaced conversation surrounding the idea that SARS-CoV-2 might have leaked from a lab in Wuhan, China, represents an opportunity to reexamine the confluence of science, politics, and public discourse.
The recent news of consumers hoarding gasoline in the face of a brief closure of one of the world’s biggest petroleum pipelines is just the latest episode of panic buying since the COVID-19 pandemic started.
Politicians should of course consider and respect the latest research findings in crafting policy, but elected officials should honor the scientific method by letting its practitioners hash out the details of the science.
This year has started out in a fashion that is sadly similar to the way 2020 unspooled. But the steady pace of scientific discovery helps maintain our sense of hope.
Last year humanity confronted our biggest challenge in a century. Science helped us see the light at the end of the tunnel. But we need to keep moving forward to emerge.